Orion Nutraceuticals Inc. reported earnings results for the full year ended May 31, 2023. For the full year, the company reported net loss was CAD 0.279691 million compared to CAD 2.62 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.09 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 CAD | -.--% | -.--% | -.--% |
Apr. 19 | Orion Nutraceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Mar. 13 | Joel Dumaresq Resigns as Director of Orion Nutraceuticals Inc | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 8.68M | |
+43.31% | 6.19B | |
-16.99% | 4.48B | |
+6.39% | 3.29B | |
-13.10% | 3.12B | |
-4.17% | 2.5B | |
+45.47% | 1.94B | |
-9.11% | 1.68B | |
-2.09% | 1.64B | |
-12.50% | 1.56B |
- Stock Market
- Equities
- ORI Stock
- News Orion Nutraceuticals Inc.
- Orion Nutraceuticals Inc. Reports Earnings Results for the Full Year Ended May 31, 2023